Katie:  There have been some good entries about antidepressants in the
past.  I'll refer you to the archives, with a particularly relevant
posting from Dr. Hale on Oct. 24, as well as Dr. Hale's post on Nov.27,
Jon Ahrendsen on Sept 27 and Sarah Barnett on Oct. 22.  Bottom line is
that the tricyclic antidepressants (e.g. desipramine, amitryptilene) tend
to have very minimal blood levels in babies and that there are no known
long-term adverse effects (by the same token, the long-term effects are
really unknown, so even these agents must be used with caution, as per
the AAPrecommendation).  As for the SSRI's (prozac, sertraline,
paroxetine), there is less known about these, and prozac is of particular
concern because of its long half-life, but even though sertraline has
been shown not to have any significant drug levels in babies, the levels
of metabolites were not measured, so it's still an unknown).  Read the
archives for more details, but probably tricyclics such as desipramine
and amitryptilene are the better choices.  Alicia.  [log in to unmask]